Ending Transmission of HIV, HCV, and STDs and Overdose in Rural Communities of People Who Inject Drugs (ETHIC)
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 306
- 试验地点
- 4
- 主要终点
- Total Participants Who Received Referrals to the Harm Reduction Services Organization
研究概览
简要总结
This study will evaluate the referral to harm reduction services (HRS) including syringe services, naloxone overdose prevention, substance use treatment referral, HIV, HCV, and STD testing and referral and linkage to care through capacity building of existing programs through client services data.
详细描述
This is a prospective longitudinal Type 1 Hybrid Implementation Effectiveness Study on the expansion of harm reduction services for people who inject drugs (PWID) and people who use opioids (PWUO) residing in high risk areas of rural southern Illinois. This study record describes one component of the larger Ending transmission of HIV, HCV, and STDs and overdose in rural communities of people who inject drugs (ETHIC) study Community Response Plan (CRP) framework, specifically the expansion of harm reduction services intervention (HRS). The aim is to assess the effectiveness of expansion of evidenced based harm reduction services through our CRP framework comprising: a) geographically targeted recruitment based on hot spot and vulnerability analyses, b) community engagement, c) recruitment via Respondent Driven Sampling (RDS), d) expanded surveillance for HIV and HCV, and e) concomitant HCV and opioid use treatment capacity expansion through the Extension of Community Healthcare Outcomes (ECHO) model. Examination of facilitators and barriers impacting implementation of service delivery is evaluated through mixed methods process evaluation. The Type 1 Hybrid design is supported by conditions including the existing evidence based for benefits and minimal harm of "harm reduction services" and strong base for applicability of this intervention in the study setting (ie rural opioid use)
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Health Services Research
- 盲法
- None
入排标准
- 年龄范围
- 15 Years 至 —（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •15 years of age and older
- •Injected any drug in the past 30 days
- •Used any opioids non-medically in the past 30 days
- •English speaking
- •Able to provide informed consent at the time of the study visit
排除标准
- •Less than 15 years of age
- •Not injected any drug in the past 30 days
- •Not used any opioids non-medically in past 30 days
- •Non-English speaking
- •Has not injected any opioid drug to get high in the past 30 days
- •Unable to provide informed consent at the time of the study visit
结局指标
主要结局
Total Participants Who Received Referrals to the Harm Reduction Services Organization
时间窗: 2 years
Number of participants who accept referral to the intervention (divided by the total enrolled who did not have previous engagement prior to the study with the harm reduction services organization).
次要结局
- Number of Times Participants Used a Syringe or Needle That They Knew Was Used by Somebody Else(2 years)
- Number of Locations Where Participants Received Most of Syringes or Needles(2 years)
- Number of Times Sterile Syringes and/or Equipment Obtained From an Intervention(2 years)
- Number of Times Participants Used a Cotton, Cooker, Spoon, or Water for Rinsing or Mixing That They Knew Was Used by Somebody Else(2 years)
- Number of Times Participants Let Someone Else Use a Cotton, Cooker, Spoon, or Water for Rinsing or Mixing After They Used it(2 years)
- Number of Participants With Drive Time Less Than 30 Minutes to Nearest Syringe or Needle Exchange(2 years)
- Number of Participants That Currently Have Naloxone(2 years)
- Number of Participants Who Received Substance Use Disorders (SUD) Treatment Referrals(2 years)
- Total Number of Participants Who Received an HIV Screening(2 years)
- Total Number of Participants Who Received an HCV Screening(2 years)
- Number of Participants With Knowledge of PrEP(6 months)
- Number of Participants Diagnosed With HIV Who Have Access to HIV Care(2 years)
- Number of Participants Diagnosed With HCV Who Have Access to HCV Care(2 years)
- Number of Times a Participant Engaged in Condomless Sex (Vaginal or Anal)(6 months)